| 6HIS | hexa-histidine |
| ADA | anti-drug antibody |
| ADCC | antibody dependant cellular cytotoxicity |
| ADCP | antibody dependant cellular phagocytosis |
| ADH1 | alcohol dehydrogenase 1 |
| AIEX | anion exchange chromatography |
| ALI | acute lung inflammation |
| ARDS | acute respiratory distress syndrome |
| aTTP | acquired thrombotic thrombocytopenic purpura |
| ALL | acute lymphoblastic leukaemia |
| AMD | age-related macular degeneration |
| AML | acute myeloid leukaemia |
| BBB | blood–brain barrier |
| BCMA | B-cell maturation antigen |
| BiKE | bispecific natural killer cell engager |
| BiTE® | bispecific T-cell engager |
| CDC | complement-dependent cytotoxicity |
| CDR | complementarity determining region |
| CEA | carcinoembryonic antigen |
| CHO | Chinese hamster ovary |
| CIEX | cation exchange chromatography |
| CL | constant domain of immunoglobulin light chain |
| CNS | central nervous system |
| CPP | cell penetrating peptide |
| dAb | Domain antibody® |
| DART® | dual affinity re-targeting protein |
| EpCAM | epithelial cell adhesion molecule |
| ER | endoplasmic reticulum |
| Fab | fragment of antigen binding |
| Fc | fragment crystallizable |
| FcRn | neonatal fragment crystallizable receptor |
| Fv | fragment variable |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase |
| GFP | green fluorescent protein |
| GM-CSF | granulocyte-monocyte colony stimulating factor |
| GST | glutathione-S transferase |
| HAVH | human anti-VH |
| HEK | human embryonic kidney |
| HER2 | human epidermal growth factor 2 |
| HIC | hydrophobic interaction chromatography |
| HIV | human immunodeficiency virus |
| HLA | human leukocyte antigen |
| IgG | immunoglobulin gamma |
| IMAC | immobilised metal affinity chromatography |
| ImmTAC® | immune mobilising monoclonal t-cell receptors against cancer |
| ImmTAV® | immune mobilising monoclonal t-cell receptors against virus antigens |
| mAb | monoclonal antibody |
| MBP | mannose binding protein |
| MDS | myelodysplastic syndrome |
| MDSC | myeloid derived suppressor cell |
| MG | myasthenia gravis |
| MHC | major histocompatibility complex |
| MS | multiple sclerosis |
| Nb | Nanobody® |
| NK cell | Natural killer cell |
| NY ESO | New York esophageal squamous cell carcinoma |
| PD | pharmacodynamic |
| PEG | polyethylene glycol |
| PGK1 | phosphoglycerate kinase 1 |
| RMT | receptor-mediated endocytosis |
| RSV | respiratory syncytial virus |
| scFv | single chain fragment variable |
| SEC | size exclusion chromatography |
| SLE | systemic lupus erythematosus |
| TBGP | anti-trophoblast glycoprotein 5T4 |
| TCR | T-cell receptor |
| TfR | transferrin receptor |
| TNF | tumour necrosis factor |
| IL | interleukin |
| TNFR1 | tumour necrosis factor receptor 1 |
| TriKE | trispecific natural killer cell engager |
| VEGF | vascular endothelial growth factor |
| VH | variable domain of immunoglobulin heavy chain |
| VL | variable domain of immunoglobulin light chain |
| V-NAR | variable new antigen receptor |
| vWF | von Willebrand factor |